ArticleInternational journal of molecular sciences2021

Combined Application of Pan-AKT Inhibitor MK-2206 and BCL-2 Antagonist Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia.

Anna Richter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.